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Metastatic rectal adenocarcinoma in the
mandibular gingiva: a case report
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and Hideyuki Sakurai3
Abstract
Background: Oral metastatic tumor from a rectal adenocarcinoma is very uncommon. The primary site is usually
assumed based on the past clinical history. In the case of oral metastatic tumors, they commonly have a poor
prognosis because often they have already spread to other sites.
Case presentation: We present the case of a 64-year-old male patient with secondary metastasis to the mandibular
gingiva via lung metastasis after the surgical resection of a primary rectal adenocarcinoma. The gingival lesion grossly
appeared as a swollen mass, making mastication difficult. The patient received palliative radiotherapy for the
mandibular mass lesion. However, tumor reduction was accompanied by the development of pneumonia and
deterioration of the patient’s cachexia. Thus, the radiotherapy was discontinued but the patient died 2 months
postradiotherapy. In the long term after its primary resection, the rectal adenocarcinoma was deduced to have
finally metastasized to the oral region.
Conclusions: In this case, we consider a distant secondary metastasis to the oral region from a rectal malignancy.
In such cases, careful clinical and pathologic evaluations are necessary, with careful consideration of the inclusion
of palliative treatment in the therapeutic management.
Keywords: Metastasis, Gingiva, Rectal adenocarcinoma
Background
Metastatic tumors to the oral cavity are rare and account
for approximately 1 % of all oral malignant neoplasms
[1]. The primary site is usually assumed based on the
past clinical history. Most patients were previously diag-
nosed in relation to a primary neoplasm and were
treated accordingly. However, 23 % of oral metastatic tu-
mors represent the first clinical sign of the metastatic
process [2]. The most common primary sites are the
lungs in men and the breast in women [2]. The peak in-
cidence of oral metastasis is observed during the age of
50–70 years [2]. In the oral cavity, hard tissues such as
the jawbone are more commonly affected than soft tis-
sues such as the gingiva [3]. The gingivae (55 %)
followed by the tongue (30 %) are the most common soft
tissue sites affected by metastatic tumor [4]. Colonic car-
cinoma is one of the most common malignant neo-
plasms worldwide. Its usual sites of metastasis are the
regional lymph nodes, liver, lungs, cutis, vagina, myocar-
dium, breast, and prostate. Metastasis to the gingiva is
particularly rare. Here, we report the case of a metastatic
rectal adenocarcinoma spreading to the mandibular gin-
giva via lung metastasis over the long clinical term of a
patient following surgical tumor resection at the primary
site.
Case presentation
A 64-year-old man with gross swelling in the anterior
mandibular gingiva for 1 month after lower incisal teeth
extraction was referred to us for a closer evaluation.
Oral examination revealed a firm mass measuring 2.6 ×
2.1 cm in size arising from the extraction site (Fig. 1).
The surface of the mass lesion showed erosion at the site
equivalent to the wounds after tooth extraction. There
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was no hemorrhage or paralysis in the mandibular re-
gion, and the condition was painless.
For the past medical history, the patient underwent
low anterior resection of a rectal malignancy diagnosed
as moderately differentiated adenocarcinoma 7 years
previously. There was no evidence of regional lymph
node and distant metastases. Three years after the pri-
mary surgery, the patient showed bilateral lung metastases.
Thus, the middle lobe of the right lung and the lower lobe
of the left lung were partly resected. Four years later, mul-
tiple lung metastases and metastases to the vertebral bod-
ies of the VI–VIII vertebrae were observed. The patient
received 60 Gy of irradiation to control the pain from the
lesion involving the vertebra.
Computed tomography (CT) scan of the head and
neck showed a solid mass and bony resorption in the
anterior alveolar ridge of the mandible (Fig. 2a). There
was no lymphadenopathy. Magnetic resonance imaging
(MRI) revealed a heterogeneous signal on a T1-weighted
image after gadolinium administration and an intense
signal on a diffusion-weighted image (Fig. 2b).
For the laboratory examination results, the serum car-
cinoembryonic antigen and cancer antigen 19-9 levels
were 947.6 ng/ml and 1059.2 U/ml, respectively. Patho-
logical examination by incisional biopsy of the gingival
mass lesion revealed a moderately differentiated adeno-
carcinoma. The tumor was composed of proliferating
columnar to polygonal epithelial cells with moderate aty-
pia that showed a papillary tubular pattern (Fig. 3a, b).
Immunohistological analysis demonstrated that the
adenocarcinoma cells were positive for cytokeratin 20
(CK20) and negative for cytokeratin 7 (CK7) and positive
for caudal type homeobox transcription factor 2 (CDX2)
(Fig. 4a–c). The biopsy findings from the mandibular mass
lesion were consistent with those from the resected rectal
carcinoma 7 years previously.
The tumor had grown gradually and an ulcer was
formed on the surface, making mastication difficult. The
patient received palliative radiotherapy for the mandibular
mass lesion. However, once the tumor showed a tendency
to decrease in size, pneumonia developed and the patient’s
cachexia deteriorated. Thus, the radiotherapy was dis-
continued, but the patient unfortunately died 2 months
postradiotherapy.
Discussion
Oral metastatic tumors are uncommon and comprise
approximately 1 % of malignant oral neoplasms [1].
Most cases were previously diagnosed in reference to a
primary neoplasm and were treated accordingly. There-
fore, the primary site is usually assumed based on the
past clinical history. However, 23 % of oral metastases
were shown to be the first sign of the metastatic process
[2]. In the present case, the origin of the metastatic le-
sion was clarified based on the past history of rectal
adenocarcinoma resection and the subsequent lung me-
tastases. The most common primary site in women is
Fig. 1 Intraoral tumor of the patient. The tumor mass measuring
2.6 × 2.1 cm in size rapidly enlarged in the medial mandibular gingiva
Fig. 2 CT and MRI images of the mandibular region (scale bar, 5 cm). a A CT image showing a solid mass in the medial mandibular gingiva with
bone destruction. b An MRI image showing a heterogeneous signal on a T1-weighted image after gadolinium administration
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the breast followed by the female genital tract, kidney, and
colon-rectum. In men, the most common primary site is
the lung followed by the kidney, liver, and prostate [2].
In the oral site where metastatic tumors arise, most
tumor lesions are observed in the jawbones, and only
16 % are found in the soft tissues such as the gingiva [3].
The metastatic rate in the posterior body of the man-
dible is higher than that in the symphyseal region [5].
The gingivae (55 %) followed by the tongue (30 %) are
the most common soft tissue sites affected by metastatic
malignancy [4]. In the present case, the metastatic lesion
has been presumed to develop in the gingival tissue of
the symphysis. This lesion was an exophytic growing
mass, and the radiological appearance of the mandibular
bone invasion was not demonstrated apparently. Like-
wise, some case reports have shown that the metastatic
site was the gingiva for the primary lesion of colonic and
rectal adenocarcinomas [6–8].
Adenocarcinoma of the colon and rectum commonly
spreads to the regional lymph nodes, liver, and lungs,
but less commonly to the peritoneum, bone, adrenal
glands, brain, kidney, thyroid, pancreas, ovaries, and skin.
Clausen and Poulsen proposed the following three criteria
for metastatic oral tumor: firstly, the metastatic tumor is
pathologically similar to the primary tumor; secondly, the
oral tumor is considered to be a metastasis clinically and
pathologically; and thirdly, the oral tumor is atypical com-
pared with common oral primary tumors [9]. The most
common primary tumor arising from the oral mucosa is
squamous cell carcinoma. Therefore, there may be a need
to differentiate metastatic adenocarcinoma from adeno-
carcinoma derived from the salivary gland, although the
frequency of occurrence is very low. Three clinical courses
may be considered to underlie the metastasis of colonic
adenocarcinoma to the oral cavity as follows: (1) direct
metastasis with identification of the primary tumor, (2)
secondary metastasis derived from metastasis in another
site after treatment of the primary tumor, and (3) occult
metastasis without identification of the primary tumor.
The present case follows the second clinical course in
which the secondary metastasis in the jawbone was de-
rived from multiple lung metastatic lesions. The primary
rectal tumor has already been resected completely. The
present case conformed to Clausen’s criteria.
Histopathologically, approximately 70 % of the metastatic
lesion in the oral region is reportedly adenocarcinoma,
followed with much less cases by clear cell carcinoma from
the kidney and squamous cell carcinoma from the lungs
[10]. Also in the present case, the hematoxylin and eosin-
stained section showed features of adenocarcinoma arising
from the rectum. Furthermore, the histological diagnosis
was supported by the immunohistochemical analysis. The
Fig. 3 Microscopic appearance of the metastatic oral tumor. The biopsy specimen obtained at the first visit to our department shows moderately
differentiated adenocarcinoma with a papillary tubular pattern comprising columnar to polygonal epithelial cells (hematoxylin and eosin stain,
original magnifications ×40 (a) and ×200 (b))
Fig. 4 Immunohistochemical staining of the metastatic oral tumor showing tumor cells negative for CK7 (a), positive for CK20 (b), and positive
for CDX2 (c) (original magnifications for all images, ×200; scale bar, 100 μm)
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metastatic tumor cells demonstrated a CK20-positive
and a CK7-negative phenotype. In the evaluation of
gastrointestinal tract carcinomas, the great majority of
well-differentiated or moderately differentiated large in-
testinal adenocarcinomas reportedly showed a CK7-
negative/CK20-positive phenotype. Adenocarcinomas
of the upper gastrointestinal tract were also reported to
be positive for both CK7 and CK20 in 78 % of cases
[11]. Thus, an assessment of the CK7 and CK20 pheno-
type may help in determining the primary site of a
metastatic tumor [11]. In addition to the CK7 and CK20
immunoprofiles, the tumor cells showed CDX2 immunore-
activity. CDX2 is a sensitive and specific maker for adeno-
carcinoma with a colorectal origin [12]. CDX2 expression
has also been shown in a subset of adenocarcinomas arising
from the colon, rectum, stomach, esophagus, and ovary
[13]. Accordingly, CK7, CK20, and CDX2 may be useful for
the diagnosis of metastatic tumors of gastrointestinal origin.
In the case of oral metastatic tumors, they usually have
a poor prognosis because often they have already spread
to other sites. Therefore, the appropriate palliative treat-
ment has to be carefully selected. If the tumor is widely
disseminated, palliative radiotherapy is recommended
[10]. However, when possible, surgical resection may be
recommended mostly for metastatic lesions in the soft
oral tissue [10]. In the present case, as the oral meta-
static lesion was rapidly growing with accompanying mul-
tiple lung metastases, resection was not possible under
general anesthesia. Accordingly, we performed pallia-
tive radiotherapy for the mandibular mass. Alterna-
tively, chemotherapy with the FOLFIRI regimen (5-FU,
leucovorin, irinotecan) is usually performed for advanced
metastatic colorectal carcinoma [6]. Although the IRIS regi-
men (irinotecan, S-1) plus bevacizumab (monoclonal anti-
body targeted against vascular endothelial growth factor)
was planned when the lung metastasis occurred to play the
role of another second-line chemotherapeutic regimen, the
patient showed no response to the chemotherapy.
Patients with distant metastasis of colorectal adenocarcin-
oma usually have a poor prognosis. In particular, if a second-
ary metastatic oral tumor is identified, the disease state may
be commonly progressive and the prognosis is extremely
poor. In cases involving metastasis to the oral cavity, the
mean survival period from the time of mass appearance to
the time of death of a patient has been reported to be about
7 months [2]. Regarding metastasis to the gingiva, some
cases have been documented showing that the duration of
survival from the indication of gingival mass development
was only within 1 year [6, 14, 15]. The present case also
showed a short survival period of 4 months.
Conclusions
We present the case of a patient with metastatic rec-
tal adenocarcinoma to the mandibular gingiva. The
metastatic oral tumor has developed as a secondary
metastasis 7 years following the resection of the primary
rectal tumor. This case indicates that careful clinical and
pathological evaluations are important in making a defini-
tive diagnosis particularly in patients with a past history of
a malignant lesion. When metastasis to the oral region is
confirmed, the patient is often already in the advanced
stage. In such a patient, therapeutic management that
includes palliative treatment must be considered.
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